2B BlackBio is Focused on Reducing Mortality Rates with Early Sepsis Detection Kit

A recent product of note is the BlackLight® Sepsis Kit, which is currently under clinical evaluation. The sepsis detection kit has been extensively tested on real hospital samples, which have led to recognition of both common and rarer pathogens.

Read more »

2B Blackbio Obtains CE Marking for Identifying Fungal Infections

2B Blackbio, dedicated to developing and marketing new solutions for personalized medicine, has obtained CE Marking for BlackLight Fungal ID Kit, intended for a fast and easy‐to‐use diagnostic test, allowing rapid identification of fungal infections.

Read more »

EpiCept Corporation Announces Year End Results and Updates On Clinical Trials Surrounding Cancer Treatment

EpiCept Corporation recently announced operating and financial results for the year 2010, and provided an update on its key business initiatives.

Read more »